EVALUATION OF THE ADVERSE-EFFECTS OF IOMEPROL

The new non-ionic contrast medium iomeprol (Iomeron(R)) 150/200/250/30 0/350/400 was tested in a non-selected patient population (n = 4811). The aim of the clinical testing, in a very diverse range of radiograph ical examinations. was to evaluate its tolerance. A high percentage of the patients showed risk factors such as allergic predisposition (22. 0%), cardiovascular diseases (45.3%), and kidney disease (15.1%). In a ddition, high doses of the contrast medium were used, depending on the radiological problem. The proportion of patients over 70 was 19.5%., Iomeprol proved to be an extremely well tolerated nonionic contrast me dium. With the exception of nausea, systemic side effects occurred in less than 1% of cases.